Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48.51%690.5K | -454.73%-777.24K | 115.70%1.46M | -2.92%1.24M | 66.06%-123.24K | -61.92%464.96K | 123.15%219.11K | -50.43%675.01K | 242.93%1.27M | -49.32%-363.1K |
| Net income from continuing operations | -25.03%-188.76K | 164.77%191.11K | -202.92%-783.09K | 13.30%-1.27M | -154.31%-929.57K | -399.16%-150.97K | 114.73%72.18K | 55.06%-258.52K | 5.45%-1.46M | -184.71%-365.52K |
| Depreciation and amortization | 0.06%376.76K | -0.04%376.16K | -0.05%376.01K | -0.42%1.51M | 0.62%379.79K | -0.43%376.52K | -0.39%376.32K | -1.45%376.22K | 86.65%1.52M | -11.42%377.46K |
| Asset impairment expenditure | ---- | ---- | ---- | --150K | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --0 | --0 | -69.63%19.41K | -35.77%157.96K | -65.39%38.43K | --0 | --55.62K | -52.61%63.92K | -25.02%245.92K | 166.88%111.03K |
| Deferred tax | 0.00%-98.75K | 0.00%-98.75K | 0.00%-98.75K | -16.58%-460.5K | -66.31%-164.24K | 0.00%-98.75K | 0.00%-98.75K | 0.00%-98.75K | -83.27%-395.01K | 14.71%-98.75K |
| Other non cashItems | -70.16%14.58K | -63.46%17.53K | -4.88%57.89K | -53.41%215K | -78.80%57.28K | -29.62%48.87K | -22.42%47.99K | 1.49%60.86K | 284.95%461.43K | 320.70%270.17K |
| Change In working capital | 102.80%586.66K | -439.34%-1.26M | 254.72%1.88M | 2.74%931.4K | 152.48%345.07K | -67.94%289.29K | 70.61%-234.24K | -63.58%531.29K | 332.84%906.6K | -23.83%-657.48K |
| -Change in receivables | -202.21%-1.32M | 172.06%316.26K | -71.03%801.89K | 526.63%4.45M | 122.58%834.35K | 83.29%1.29M | -41.99%-438.88K | -31.01%2.77M | 118.73%710.71K | 5.99%-3.7M |
| -Change in prepaid assets | 116.35%74.92K | 8.58%-110.15K | -19.90%72.6K | 38.08%-35.42K | -19.20%-40.19K | -1.86%34.63K | -1.38%-120.49K | 50.85%90.63K | -159.43%-57.2K | -142.57%-33.72K |
| -Change in payables and accrued expense | 254.96%1.61M | -544.41%-1.47M | 143.31%1.01M | -1,195.44%-3.49M | -113.50%-449.09K | -937.94%-1.04M | 203.04%330.65K | 17.01%-2.33M | -91.21%318.3K | -8.91%3.33M |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.20%5.53K | 79.10%-65.21K | 23.11%-254.16K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.51%690.5K | -454.75%-777.29K | 115.71%1.46M | -2.92%1.24M | 66.06%-123.24K | -61.92%464.96K | 123.15%219.11K | -50.42%675.01K | 242.93%1.27M | -49.32%-363.1K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -6.95%-10.08K | -7.94K | 0 | -58.18%-17.47K | -3.54K | -9.43K | 0 | 59.26%-4.5K | 99.77%-11.04K | 0 |
| Net PPE purchase and sale | -6.95%-10.08K | ---7.94K | --0 | -58.18%-17.47K | ---3.54K | ---9.43K | --0 | 59.26%-4.5K | -927.16%-11.04K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---9.43K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6.95%-10.08K | ---7.94K | --0 | -58.18%-17.47K | ---3.54K | ---9.43K | --0 | 59.26%-4.5K | 99.77%-11.04K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 35.06%-208.79K | 125.50%76.37K | -40.39%-780.38K | 8.98%-1.64M | -179.42%-460.76K | 69.03%-321.52K | -170.32%-299.47K | 68.54%-555.85K | -131.43%-1.8M | 240.64%580.12K |
| Net issuance payments of debt | 35.66%-208.79K | 125.50%76.37K | -40.39%-780.38K | -3.15%-2.09M | -257.08%-911.26K | 68.75%-324.52K | -170.32%-299.47K | 72.14%-555.85K | -144.94%-2.03M | 205.96%580.12K |
| Net common stock issuance | ---- | ---- | ---- | 98.90%453.5K | --450.5K | --3K | --0 | --0 | -81.21%228K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 35.06%-208.79K | 125.50%76.37K | -40.39%-780.38K | 8.98%-1.64M | -179.42%-460.76K | 69.03%-321.52K | -170.32%-299.47K | 68.54%-555.85K | -131.43%-1.8M | 240.64%580.12K |
| Net cash flow | ||||||||||
| Beginning cash position | -88.49%63.31K | 22.49%772.17K | -81.29%96.5K | -51.03%515.73K | 129.21%684.67K | 374.08%550.03K | -1.01%630.38K | -51.03%515.73K | 4.66%1.05M | -82.52%298.7K |
| Current changes in cash | 250.27%471.62K | -782.14%-708.86K | 489.29%675.67K | 21.98%-419.22K | -371.02%-588.17K | -26.30%134.65K | 84.57%-80.36K | 127.55%114.66K | -1,245.45%-537.32K | 133.10%217.02K |
| End cash Position | -21.87%534.93K | -88.49%63.31K | 22.49%772.17K | -81.29%96.5K | -81.29%96.5K | 129.21%684.67K | 374.08%550.03K | -1.01%630.38K | -51.03%515.73K | -51.03%515.73K |
| Free cash from | 49.37%680.41K | -458.38%-785.24K | 117.16%1.46M | -3.45%1.22M | 66.11%-126.78K | -62.69%455.53K | 123.43%219.11K | -50.34%670.51K | 241.52%1.26M | -53.18%-374.14K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.